By Jason Derry —

Affymetrix Inc. and Baylor College of Medicine have entered into an
agreement in which Baylor receives a non-exclusive, worldwide license to use
Affymetrix's comparative genomic hybridization (CGH) microarrays.  Baylor intends to use the microarrays in
services provided in Clinical Laboratory Improvement Amendments (CLIA) environments.  The Press Release providing this news can be found here.

Jason Derry, Ph.D., who graduated with honors from DePaul University
College of Law, is a molecular biologist and founding author of Patent Docs.